Portfolio: Biotechnology
Syndax Pharmaceuticals, Inc.
Novel combination regimens for cancer
Theraclone Sciences
Novel tumor-specific therapeutic antibodies
Verastem
Novel drugs that selectively target cancer stem cells
VLST Corporation
Inflammatory and autoimmune disease therapeutics
Xanodyne Pharmaceuticals, Inc.
Therapeutic products for women's health and pain management
Zalicus (f/k/a CombinatoRx, Inc.)
A biopharmaceutical company developing new and improved pain therapies